Skip to main content

Zusammenfassung

Proliferation vaskulärer Strukturen, spindelförmige Zellen und extravasale Erythro­zyten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Kotz KW, Krigel RL (1993) “Epidemic Kaposi’s Sarcoma”. In: Meiderhuber (ed) Current Therapy in Oncology

    Google Scholar 

  2. Serraino D, Franceschi S, Tirelli U et al. (1992) The epidemiobgy of acquired immune defldiency and associated tumours in Europe. Ann Onc 3: 595–603

    CAS  Google Scholar 

  3. Beral V, Peterman TA, Berkelman RL et al. (1990) Kaposi’s Sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335: 123–128

    Article  PubMed  CAS  Google Scholar 

  4. Bunikowski R, Estemiann J, Koch M (1992) AIDS in Germany: Clinical manifestations of AIDS. Medizinische Klinik 87: 1–7

    Google Scholar 

  5. Armes J (1989) A review of Kaposi’s Sarcoma. Adv Ca Res 53: 73–87

    Article  CAS  Google Scholar 

  6. Huang YO, Li JJ, Resh MG et al. (1992) HPV-16-related DNA sequences in Kaposi’s Sarcoma. Lancet 339: 515–518

    Article  PubMed  CAS  Google Scholar 

  7. Chachoua A, Krigel R, Lafleur et al. (1989) Prognostic factors and staging classification of patients with epidemic Kaposi’s Sarcoma. J Clin Oncol 7: 774–780

    PubMed  CAS  Google Scholar 

  8. Krown SE, Metroka C, Wernz JC et al. (1989) Kaposi’s Sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7: 1201-1207

    Google Scholar 

  9. Epstein JB, Lozada-Nur F, McLeod A et al. (1989) Oral Kaposi’s Sarcoma in acquired immunodeficiency syndrome: Review of management and report of the efficacy of intralesional vinblastine. Cancer 64: 2424-2430

    Google Scholar 

  10. Berson AM, Quivey JM, Harris JW et al. (1990) Radiation therapy for AIDS-Related Kaposi’s Sarcoma. Int J Rad Onc Biol Phys 19: 569–575

    Article  CAS  Google Scholar 

  11. Gill PS, Loureiro C, Bernstein-Singer M et al. (1989) Clinical effect of glucocorticoids on Kaposi’s Sarcoma related to the acquired immunodeficiency syndrome ( AIDS ). Ann Int Med 110: 937-940

    Google Scholar 

  12. Hirsch M, D’Aquilla RT (1993) Therapy for human immunodeficiency virus infection. N Engl J Med 328: 1686–1695

    Article  PubMed  CAS  Google Scholar 

  13. Ensoli B, Barillari G, Salahuddin SZ et al. (1990) Tat protein of HIV stimulates growth of cells derived from Kaposi’s Sarcoma lesions of AIDS patients. Nature 345: 84 – 86

    Article  PubMed  CAS  Google Scholar 

  14. Palca J (1992) Kaposi’s Sarcoma gives on key fronts. Science 255: 1352–1364

    Article  PubMed  CAS  Google Scholar 

  15. Nakamura S, Sakurada S, Salahuddin SZ et al. (1992) Inhibition of development of Kaposi’s Sarcoma-related lesions by a bacterial cell wall complex. Science 285: 1437–1440

    Article  Google Scholar 

  16. Wallstein K, Zugmaier G, Calitano J et al. (1991) Tumor growth dependent on Kaposi’s Sarcoma-derived Fibroblast Growth Factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83: 716–720

    Article  Google Scholar 

  17. Evana LM, Itri IM, Campion M et al. (1991) Interferon-alpha in the treatment of acquired immunodeficiency syndrome-related Kaposi’s Sarcoma. J Immunother 10: 39–50

    Article  Google Scholar 

  18. Volberding PA, Abrams DI, Conant M et al. (1985) Vinblastine therapy for Kaposi’s Sarcoma in the acquired immunodeficiency syndrome. Ann Int Med 103: 335–338

    Article  PubMed  CAS  Google Scholar 

  19. Mintzer DM, Real FM, Jovino L et al. (1985) Treatment of Kaposi’s Sarcoma and thrombocytopenis with vincristine in patients with acquired immunodeficiency syndrome. Ann Int Med 102: 200–202

    Article  PubMed  CAS  Google Scholar 

  20. Laubenstein LF, Krigel RL, Odajnyk CM et al. (1984) Treatment of epidemic Kaposi’s Sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2: 1115–1130

    PubMed  CAS  Google Scholar 

  21. Lassoued K, Clauval J, Katlama C et al. (1990) Treatment of the acquired immune deficiency syndrome-related Kaposi’s Sarcoma with bleomycin as a single agent. Cancer 66: 1869–1872

    Article  PubMed  CAS  Google Scholar 

  22. Gill PS, Rarick M, McCutchan A et al. (1991) Systemic treatment of AIDS-related Kaposi’s Sarcoma: Results of a randomized trial. Am J Med 90: 427–433

    Google Scholar 

  23. Kaplan L, Abrams D, Volberding P (1986) Treatment of Kaposi’s Sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 70: 1121–1122

    PubMed  CAS  Google Scholar 

  24. Gill P, Rarick M, Bernstein-Singer M et al. (1990) Treatment of advanced Kaposi’s Sarcoma using a combination of bleomycin and vincristine. J Clin Oncol 13: 315–319

    Article  CAS  Google Scholar 

  25. Rarick MU, Gill PS, Montgomery T et al. (1990) Treatment of epidemic Kaposi’s Sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1: 147–149

    PubMed  CAS  Google Scholar 

  26. Presant CA, Scolaro M, Kennedy P et al. (1992) Liposomal daunorubicin as tumor-targeted chemotherapy: Initial clinical results in Kaposi’s Sarcoma and solid tumors. Proc Am Soc Clin Oncol 11: 46

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kotz, K., Krigel, R.L. (1993). Kaposi-Sarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics